Nachrichten zur Eli Lilly & Co. Aktie

Eli Lilly to Expand Pain Pipeline With $1B SiteOne Buyout Offer

LLY inks $1B deal to acquire SiteOne, adding phase II-ready pain drug STC-004 to strengthen its neuroscience pipeline.…

Eli Lilly greift nach Zukunft der Schmerzmedizin! SiteOne Therapeutics Deal soll Opioid-Alternativen vorantreiben!

Der Pharmariese Eli Lilly (LLY) übernimmt laut einer Pressemitteilung vom Dienstag, den 27. Mai 2025, das Privatunternehmen SiteOne Therapeutics und…

Eli Lilly vs. AstraZeneca: Which Pharma Powerhouse is the Better Buy?

Lilly dominates GLP-1 market but faces near-term headwinds, while AstraZeneca boasts steady growth, rising estimates and a higher dividend yield.…

Eli Lilly to buy SiteOne for $1 billion with eye on non-opioid pain drug

Eli Lilly will buy privately held SiteOne Therapeutics in a deal worth as much as $1 billion, the companies said…

Eli Lilly expands neuroscience pipeline with $1B acquisition of SiteOne therapeutics

Eli Lilly and Co (NYSE:LLY) announced it is acquiring SiteOne Therapeutics, a private biotech firm developing small-molecule inhibitors of sodium…

Eli Lilly expands neuroscience pipeline with $1B SiteOne acquisition

Eli Lilly and Co (NYSE:LLY) announced it is acquiring SiteOne Therapeutics, a private biotech firm developing small-molecule inhibitors of sodium…

Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics By Investing.com

Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics…

Prediction: These 2 Stocks Will Beat the Market in the Next Decade

Investors typically want to beat the market over the long run. Though its not an easy task, it certainly is…

Investing for the Long Term: 1 Unstoppable Vanguard ETF to Buy and Hold Forever

The Vanguard Growth ETF (NYSEMKT: VUG) is an exchange-traded fund (ETF) that exclusively holds large-cap stocks. It has outperformed the…

Top Analyst Reports for Eli Lilly, GE Aerospace & Amgen

Todays Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), GE Aerospace (GE)…

Cigna takes different approach with GLP-1s, more favorable for Eli Lilly By Investing.com

Cigna takes different approach with GLP-1s, more favorable for Eli Lilly…

Cigna’s $200 Weight-Loss Drug Cap Shakes Up Hims & Hers Stock

Hims & Hers Health Inc. (HIMS) declined 4.45% to $55.50, with an intraday low of $51.20, as Cigna’s (CI) Evernorth…

Better Weight Loss Stock: Amgen or Viking Therapeutics?

Investors looking to cash in on the fast-growing market for weight management medicines will naturally turn to the two leaders…

Cigna announces new deal for copay caps on Eli Lilly and Novo Nordisk weight loss drugs

Cignas pharmacy benefits unit Evernorth said the deal will bring prices down for employers and their workers.…

Great News for Eli Lilly Stock Investors!

Eli Lilly (NYSE: LLY) is encouraged by trial data for its latest weight-loss and diabetes medications. Where to invest $1,000 right…

Novo Nordisk is betting on a CEO shake-up to regain its weight loss drug edge over Eli Lilly

Novo Nordisks new top executive will need to help the company close the gap with Eli Lilly, fend off emerging…

Amid US investment push, Lilly eyes Houston as potential home for $5.9B API plant

With $27 billion earmarked to expand its U.S. production footprint starting this year, Eli Lilly is busy scouting out potential…

Huge News for Eli Lilly Stock Investors!

Eli Lilly (NYSE: LLY) has a strong pipeline of new medicines that could increase the stock price. *Stock prices used were…

Why Is Eli Lilly Stock Crashing and Is It a Buying Opportunity?

Eli Lilly (NYSE: LLY) is gaining market share in a lucrative market that could be a catalyst for a stock…

Huge News for Eli Lilly Stock Investors!

Eli Lilly (NYSE: LLY) has a strong pipeline of new medicines that could increase the stock price.…

Zepbound, Mounjaro sales buoy Eli Lilly family endowment

…

Eli Lilly: Obesity Drug Development To Go Beyond That Of Zepbound

…

Weight-Loss Drug Craze Boosts $80 Billion Lilly Endowment to Largest in US

The endowment started by the founding family of drugmaker Eli Lilly saw its assets surge to $80 billion at the end of 2024, passing Bill…

Trumps EO Targets Big Pharma Stocks like Eli Lilly

Trumps order looking to cut prescription drug prices is bearish for drug stocks at the surface, but is the worst…

2 Monster Stocks in the Making to Buy Now and Hold for 10 Years

Investing in promising companies before their stock prices soar is an excellent recipe for earning life-changing returns. However, with hundreds…

The Zacks Analyst Blog Highlights J&J, Eli Lilly, Pfizer, Merck, Amgen

J&J, Eli Lilly, Pfizer, Merck, Amgen are included in this Analyst Blog.…

Fox One, SoftBank delays investment, Zepbound weight loss

Yahoo Finance host Brad Smith tracks todays top moving stocks and biggest market stories in this Market Minute, including Foxs (FOX,…

Eli Lilly stock sinks as pharma misses out on the market rally

Pharma companies were mostly left out of the stock market’s broader rally Monday morning on the news that President Donald…

Stocks making the biggest moves premarket: Nvidia, Best Buy, Eli Lilly, Tesla, Amazon and more

These are the stocks posting the largest moves in premarket trading.…

Eli Lilly’s Zepbound outperforms Novo Nordisk’s Wegovy in obesity drug trial

Eli Lilly and Co (NYSE:LLY)’s weight loss drug Zepbound (tirzepatide) has shown superior results compared to Novo Nordisk (NYSE:NVO)’s Wegovy…

Billionaire Chase Coleman Has 68% of His $24.5 Billion Portfolio Invested in 10 Stocks. Heres the Best of the Bunch.

At age 49, Chase Coleman III is relatively young to be one of the wealthiest people on the planet. But…

Eli Lilly’s Zepbound outperforms Novo Nordisk’s Wegovy in weight loss trial By Investing.com

Eli Lilly’s Zepbound outperforms Novo Nordisk’s Wegovy in weight loss trial…

Eli Lilly’s Zepbound outperforms Novo Nordisk’s Wegovy for weight loss in trial By Reuters

Eli Lilly’s Zepbound outperforms Novo Nordisk’s Wegovy for weight loss in trial…

President Trump Just Announced Terrible News for Eli Lilly Investors

President Donald Trumps second term in office has been challenging for investors, at least so far. Trump imposed sweeping tariffs…

Prediction: These 2 Stocks Will Join the Trillion-Dollar Club by 2030

There is a small, exclusive group of companies with market caps above $1 trillion. Over time, more corporations will join…

Eli Lilly investing $250 million in research at Purdue University

Its one of the largest such agreements in the country.…

Eli Lilly expands Purdue University partnership with $250M investment

Eli Lilly is investing more in its home state of Indiana,…

4 No-Brainer Stocks to Buy Right Now

Market volatility and near-term uncertainty can be challenging to deal with these days -- or at any time. However, even…

One of the Largest Teacher Pension Funds in the U.S. Sold Nvidia, Tesla, and Apple and Piled Into a Popular Pharmaceutical Stock Up 395% Over the Last 5 Years

With the second quarter of 2025 now over a month old, many investment funds will soon begin disclosing what stocks…

dpa-AFX ProFeed